Role of the BMP6 protein in breast cancer and other types of cancer.
Andrea Marlene García MuroAzaria García RuvalcabaLourdes Del Carmen Rizo de la TorreJosefina Yoaly Sánchez LópezPublished in: Growth factors (Chur, Switzerland) (2021)
The BMP6 protein (Bone Morphogenetic Protein 6) is part of the superfamily of transforming growth factor-beta (TGF-β) ligands, participates in iron homeostasis, inhibits invasion by increasing adhesions and cell-cell type interactions and induces angiogenesis directly on vascular endothelial cells. BMP6 is coded by a tumor suppressor gene whose subexpression is related to the development and cancer progression; during neoplastic processes, methylation is the main mechanism by which gene silencing occurs. This work presents a review on the role of BMP6 protein in breast cancer (BC) and other types of cancer. The studies carried out to date suggest the participation of the BMP6 protein in the epithelial-mesenchymal transition (EMT) phenotype, cell growth and proliferation; however, these processes are affected in a variable way in the different types of cancer, the methylated CpG sites in BMP6 gene promoter, as well as the interaction with other proteins could be the cause of such variation.
Keyphrases
- epithelial mesenchymal transition
- transforming growth factor
- papillary thyroid
- mesenchymal stem cells
- endothelial cells
- squamous cell
- dna methylation
- bone regeneration
- signaling pathway
- genome wide
- childhood cancer
- amino acid
- stem cells
- physical activity
- squamous cell carcinoma
- cell therapy
- genome wide identification